SciBase Holding AB has expanded its collaboration and license agreement with Castle Biosciences and entered into a new loan agreement. Under the terms, Castle Biosciences will provide SciBase with a five-year loan totaling SEK 20 million. The loan carries an interest rate of STIBOR plus 2% per annum, with interest payments due quarterly starting March 31, 2026. The loan is to be repaid in cash within five years, or, at Castle's request, may be converted into new SciBase shares at a price based on the volume weighted average price over the 30 trading days preceding repayment. The loan is secured by a share pledge over SciBase's shares in SciBase AB. The funding will support SciBase's production ramp-up and continued growth, particularly in skin barrier health and skin cancer diagnostics.